Skip to content
A New Drug for ALS? episode artwork

Dec 21, 2011 6 min

A New Drug for ALS?

from Neurology Now Podcast

Merit Cudkowicz, MD, of Harvard Medical School, discusses the results of a phase 2 study—a reduction in functional decline and a significant drop in the death rate in those on the highest dose of the drug, dexpramipexole. See the Dec. 15 issue of Neurology Today for the full-text article: http://bit.ly/uqFbG7.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

A New Drug for ALS?

0:00 6:58

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Neurology Now Podcast?

This episode is 6 minutes long.

When was this Neurology Now Podcast episode published?

This episode was published on December 21, 2011.

Can I download this Neurology Now Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.